DOJ and HHS-OIG Announce Coordinated Policy on Healthcare Fraud Disclosures
DOJ's National Fraud Enforcement Division and HHS-OIG have aligned their handling of voluntary self-disclosures in healthcare fraud matters, a change defense counsel should weigh before a client reports.
On October 15, 2026, the Department of Justice's National Fraud Enforcement Division and the Department of Health and Human Services Office of Inspector General announced a coordinated policy on voluntary self-disclosures in healthcare fraud matters, according to Goodwin Procter. The announcement indicates that the two enforcement bodies have moved toward aligned treatment of self-disclosures rather than handling them independently — a recurring source of uncertainty for companies and executives weighing whether to report suspected fraud to one agency, the other, or both.
The significance here is procedural rather than plainly substantive. The available reporting describes the announcement but does not spell out the policy's terms: how the agencies will sequence their reviews, what credit a disclosing entity can expect, or whether a submission to one agency is treated as a disclosure to the other. Until the policy text is published, its practical effect on disclosure strategy should be treated as unconfirmed.
Practical next steps: obtain the published policy and any accompanying guidance, and re-evaluate disclosure strategy for pending or anticipated healthcare fraud matters before any filing is made. Watch for implementation details and follow-on releases clarifying eligibility standards, cooperation credit, and whether referrals between the agencies become a single track.